Cadonilimab Combined With Gemcitabine and Cisplatin as First Line Therapy in Patients With Advanced Intrahepatic Cholangiocarcinoma: A Single Center, Single Arm, Phase II Trial
Latest Information Update: 06 Nov 2023
At a glance
- Drugs Cadonilimab (Primary) ; Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
Most Recent Events
- 28 Mar 2023 New trial record